Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04965064
Brief Title: Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling

First Submitted : July 2, 2021
First Submitted that Met QC Criteria : July 14, 2021
First Posted : July 16, 2021

Last Update Submitted that Met QC Criteria : July 14, 2021
Last Update Posted : July 16, 2021